Our first step was to identify regulatory regions (such as promoters and enhancers) bound by ARID3B via ChIP-Chip analysis in ovarian cancer cells overexpressing ARID3B (6XHis-ARID3B). This evidence concerns the gene ARID3B and ovarian carcinoma.